2 FTSE 100 dividend stocks I’d buy and hold for the next 10 years

These two FTSE 100 (INDEXFTSE:UKX) shares could offer income investing potential in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With the FTSE 100 having a dividend yield of around 4.3%, there are numerous income investing opportunities available to investors at the present time.

In the long run, many of those companies could offer improving financial performance that boosts their share prices. And, since their valuations continue to be low in many cases, now could be the right time to buy them.

Here are two prime examples of dividend stocks that could outperform the FTSE 100 in the next decade.

GSK

Healthcare companies such as GSK (LSE: GSK) could experience strong earnings growth over the next 10 years. Demand for a range of healthcare services and drugs is likely to increase as the world’s population grows in size and also continues to see its average age rise.

GSK’s recent updates have shown that it is making progress in implementing its current strategy. This includes a joint venture within its consumer health brands portfolio, as well as M&A activity within its pharma sector. These changes could catalyse its financial performance and increase its appeal among investors.

The company’s dividend has been frozen on a per share basis over recent years. This has been a positive move in terms of the overall financial health of the business, since it now means that dividends are covered 1.5 times by net profit. There may now be scope for shareholder payouts to increase at a brisk pace, while a dividend yield of 4.5% is competitive compared to other FTSE 100 stocks.

With GSK trading on a price-to-earnings (P/E) ratio of 15, it seems to offer good value for money given its long-term prospects. As such, now could be the right time to buy a slice of it.

Berkeley

Another FTSE 100 share that could be worth buying and holding for the next decade is Berkeley (LSE: BKG). The prime housebuilder, which focuses on the London market, has experienced a challenging set of trading conditions in recent years.

Planning difficulties and lower demand following the EU referendum have contributed to weaker levels of profitability. However, the company is placed favourably to benefit from an improvement in the London housing market, where it has a large market share compared to many of its sector peers.

Encouragingly, Berkeley has a strong balance sheet and an ability to focus on long-term projects. This strategy is performing relatively well according to its recent updates, with the company on track to meet its medium-term financial guidance.

With the stock forecast to pay a dividend yield of 3.5% in the current year and 4.1% next year, it continues to offer sound income opportunities. And, with the London property market having the potential to gain ground as political risk subsides, now could be the right time to buy a slice of the stock and hold it for the long run.

Peter Stephens owns shares of Berkeley Group Holdings and GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

UK supporters with flag
Investing Articles

Why I think this super-cheap growth stock will lead the charge when the FTSE 100 recovers

Harvey Jones is seriously excited by this FTSE 100 growth stock but he also cautions that it can be very…

Read more »

Hydrogen testing at DLR Cologne
Investing Articles

Rolls-Royce’s share price is rallying again! But for how long?

Rolls-Royce's share price is the FTSE 100's best performer at the start of the new month. The question is, can…

Read more »

Lady taking a bottle of Hellmann's Real Mayonnaise from a supermarket shelf
Investing Articles

Value investors: Unilever shares are down 7% in a day!

Has the stock market’s reaction to Unilever’s deal to sell its food businesses left the reamining company as an undervalued…

Read more »

Close-up of children holding a planet at the beach
Investing Articles

The stock market is changing fundamentally — and most investors haven’t noticed

Andrew Mackie argues the FTSE 100 is being misread — beneath the volatility, investors are rotating into cash-generating businesses, not…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

FTSE 100 shares: the ‘old economy’ trade the market may be misreading

Andrew Mackie argues recent FTSE 100 volatility is masking a deeper shift, as investors rotate into cash-generative 'old economy' winners.

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Down 19% to under £1, here’s why Lloyds shares look a bargain to me anywhere up to £1.80

Lloyds' shares are down a lot in a short time, but the price doesn’t reflect how well the business is…

Read more »

Hydrogen testing at DLR Cologne
Investing Articles

£20,000 invested in Rolls-Royce shares 3 years ago is now worth…

Rolls‑Royce shares are down after a huge surge from 2023, but the numbers suggest this rare dip could be a…

Read more »

ISA Individual Savings Account
Investing Articles

How big must an ISA be to aim for a £25,000+ a year second income?

Ahead of the 5 April ISA deadline, I double-checked I had fully utilised my tax-free allowance by topping up my…

Read more »